Skip to Content
Merck has doubled down on “impact” investing—taking stakes in smaller companies that aim to generate a measurable social good. Its portfolio currently commits about $39 million to entities working on projects including diagnostics, drug and vaccine R&D, and health infrastructure. It’s a future play with present benefits: Merck estimates more than 9 million people benefited from its impact portfolio in 2019.
Courtesy of Merck
Lists ranking Merck
Change the World - 2020As we face unprecedented collective challenges, co...READ MOREview in list
Global 500 - 2020This year's Global 500 generated $33.3 trillion in...READ MOREview in list
Fortune 500 - 2020This year's Fortune 500 marks the 66th running of ...READ MOREview in list